{"id":60874,"title":"Eltrombopag and high-dose dexamethasone as frontline treatment of newly diagnosed immune thrombocytopenia in adults.","abstract":"","date":"2014-06-20","categories":"Hemic and Lymphatic Diseases","split":"train","url":"http://www.ncbi.nlm.nih.gov/pubmed/24802773","annotations":[{"name":"Therapy","weight":0.468282,"wikipedia_article":"http://en.wikipedia.org/wiki/Therapy"},{"name":"Thrombocytopenia","weight":0.202124,"wikipedia_article":"http://en.wikipedia.org/wiki/Thrombocytopenia"},{"name":"Immunity (medical)","weight":0.187046,"wikipedia_article":"http://en.wikipedia.org/wiki/Immunity_(medical)"},{"name":"Dexamethasone","weight":0.108635,"wikipedia_article":"http://en.wikipedia.org/wiki/Dexamethasone"},{"name":"Eltrombopag","weight":0.0297972,"wikipedia_article":"http://en.wikipedia.org/wiki/Eltrombopag"}]}
